Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > So We wait

<< Previous

Bullboard Posts

Next >>

Post by crow27on Dec 15, 2020 5:10pm

171 Views

Post# 32112871

So We wait

Does go up and down with very little volume. Tryed to buy around that $3.70 but it moved up very quiickly on next to no volume. !0,000 shares would run it up .15 cents
If we get the right news then this will climb very quickly.
We really have had no earth shattering news yet but when it comes you want to be in to win.
It will be wild when the right news comes and that news could happen at anytime. It could be tomorrow or 2 months from now ................. who knows?? Keep gathering while no one really wants it.
GLTA

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario